SWOT Analysis for Niagen Bioscience Inc.

30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
High Normalized Momentum Score
Consistent Highest Return Stocks over Five Years - Nifty500
Strong Momentum: Price above short, medium and long term moving averages
Expensive Rockets (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over Half Year (6 Months)
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Weekly Strategy: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 10 Years
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Increasing Revenue every Quarter for the past 4 Quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Increasing profits every quarter for the past 3 quarters
Top Gainers
RSI indicating price strength
Volume Shockers
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter